JP2014530610A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530610A5 JP2014530610A5 JP2014535698A JP2014535698A JP2014530610A5 JP 2014530610 A5 JP2014530610 A5 JP 2014530610A5 JP 2014535698 A JP2014535698 A JP 2014535698A JP 2014535698 A JP2014535698 A JP 2014535698A JP 2014530610 A5 JP2014530610 A5 JP 2014530610A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- homology
- nucleic acid
- acid molecule
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims 9
- 102000039446 nucleic acids Human genes 0.000 claims 9
- 150000007523 nucleic acids Chemical class 0.000 claims 9
- 239000012634 fragment Substances 0.000 claims 8
- 239000002773 nucleotide Substances 0.000 claims 8
- 125000003729 nucleotide group Chemical group 0.000 claims 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 7
- 108010008038 Synthetic Vaccines Proteins 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 229940124551 recombinant vaccine Drugs 0.000 claims 5
- 229960005486 vaccine Drugs 0.000 claims 4
- 241000700605 Viruses Species 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 230000002238 attenuated effect Effects 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 206010046865 Vaccinia virus infection Diseases 0.000 claims 1
- 238000004520 electroporation Methods 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 229940124590 live attenuated vaccine Drugs 0.000 claims 1
- 229940023012 live-attenuated vaccine Drugs 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 208000007089 vaccinia Diseases 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014535698A JP6567824B2 (ja) | 2011-10-12 | 2011-10-12 | ヒトパピローマウイルスのワクチンおよびその使用方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014535698A JP6567824B2 (ja) | 2011-10-12 | 2011-10-12 | ヒトパピローマウイルスのワクチンおよびその使用方法 |
| PCT/US2011/055932 WO2013055326A2 (en) | 2011-10-12 | 2011-10-12 | Vaccines for human papilloma virus and methods for using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017138165A Division JP6795468B2 (ja) | 2017-07-14 | 2017-07-14 | ヒトパピローマウイルスのワクチンおよびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530610A JP2014530610A (ja) | 2014-11-20 |
| JP2014530610A5 true JP2014530610A5 (enExample) | 2015-01-08 |
| JP6567824B2 JP6567824B2 (ja) | 2019-08-28 |
Family
ID=51938961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014535698A Active JP6567824B2 (ja) | 2011-10-12 | 2011-10-12 | ヒトパピローマウイルスのワクチンおよびその使用方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6567824B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6795468B2 (ja) * | 2017-07-14 | 2020-12-02 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | ヒトパピローマウイルスのワクチンおよびその使用方法 |
| JPWO2021095838A1 (enExample) * | 2019-11-15 | 2021-05-20 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1090033B2 (en) * | 1998-06-24 | 2007-12-19 | Innogenetics N.V. | Particles of hcv envelope proteins: use for vaccination |
| AU2003215244A1 (en) * | 2002-02-14 | 2003-09-04 | Curagen Corporation | Complexes and methods of using same |
| AU2008331673B2 (en) * | 2007-11-12 | 2014-12-11 | The Trustees Of The University Of Pennsylvania | Novel vaccines against multiple subtypes of influenza virus |
| JP5788676B2 (ja) * | 2008-01-11 | 2015-10-07 | イノビオ ファーマシューティカルズ，インコーポレイティド | デングウイルスの複数のサブタイプに対する新規ワクチン |
| CN107083391A (zh) * | 2008-04-04 | 2017-08-22 | 宾夕法尼亚大学托管会 | 屈曲病毒蛋白共有序列、编码该屈曲病毒蛋白共有序列的核酸分子和组合物及其使用方法 |
| EP2324113B8 (en) * | 2008-08-08 | 2018-04-04 | Takeda Vaccines, Inc. | Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| CA3001374A1 (en) * | 2008-11-17 | 2010-05-20 | Vgx Pharmaceuticals, Llc | Antigens that elicit immune response against flavivirus and methods of using same |
| CN102286104B (zh) * | 2010-06-21 | 2013-10-16 | 中国疾病预防控制中心病毒病预防控制所 | Hpv6型l2n120e7e6融合蛋白基因、表达载体、方法、菌株和用途 |
| CN102228698B (zh) * | 2011-06-28 | 2013-12-18 | 广西医科大学附属肿瘤医院 | Hpv58型治疗性复合基因疫苗及其构建方法 |
-
2011
- 2011-10-12 JP JP2014535698A patent/JP6567824B2/ja active Active